| Common Stock, Shares Authorized |
400,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
106,449,867 |
shares |
-0.37% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$72,800,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$146,400,000 |
USD |
-8.8% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$63,300,000 |
USD |
0.16% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$67,000,000 |
USD |
-9% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$72,100,000 |
USD |
-11% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$167,400,000 |
USD |
108% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$90,000,000 |
USD |
-13% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$308,700,000 |
USD |
-14% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$12,200,000 |
USD |
-17% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.06 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$2,400,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$17,900,000 |
USD |
-20% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$11,300,000 |
USD |
-2.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$21,300,000 |
USD |
7% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$16,000,000 |
USD |
7.4% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$9,300,000 |
USD |
-14% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$91,400,000 |
USD |
-6.3% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,700,000 |
USD |
-64% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$10,700,000 |
USD |
-38% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$12,800,000 |
USD |
-43% |
Q3 2025 |
Q3 2025 |